Literature DB >> 6849117

Guanosine triphosphate activation of brain adenylate cyclase: enhancement by long-term antidepressant treatment.

D B Menkes, M M Rasenick, M A Wheeler, M W Bitensky.   

Abstract

Activation of adenylate cyclase by a stable guanosine 5'-triphosphate analog was augmented in brain membrane preparations from rats treated on a long-term basis with tricyclic antidepressants or electroconvulsive shock. These treatments may facilitate cyclase activation by promoting the interaction of the regulatory and catalytic subunits of the enzyme. This finding suggests a possible mechanism for the changes in sensitivity to various neurotransmitters seen after antidepressant administration.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6849117     DOI: 10.1126/science.6849117

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  21 in total

1.  Antidepressants Accumulate in Lipid Rafts Independent of Monoamine Transporters to Modulate Redistribution of the G Protein, Gαs.

Authors:  Samuel J Erb; Jeffrey M Schappi; Mark M Rasenick
Journal:  J Biol Chem       Date:  2016-07-18       Impact factor: 5.157

2.  Electroconvulsive treatment: effects on phospholipase C activity and GTP binding activity in rat brain.

Authors:  A Nishida; H Kaiya; T Tohmatsu; S Wakabayashi; Y Nozawa
Journal:  J Neural Transm Gen Sect       Date:  1990

Review 3.  Dysbalance of neuronal second messenger function in the aetiology of affective disorders: a pathophysiological concept hypothesising defects beyond first messenger receptors.

Authors:  H Wachtel
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

4.  Clonidine inhibits the isoproterenol-induced desensitization of the beta noradrenergic activated adenylate cyclase system in astrocytes.

Authors:  W J Northam; P L Mobley
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

5.  Direct influence of antidepressants on GTP binding protein of adenylate cyclase in cell membranes of the cerebral cortex of rats.

Authors:  K Yamaoka; T Nanba; S Nomura
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

6.  Chronic treatment with escitalopram but not R-citalopram translocates Galpha(s) from lipid raft domains and potentiates adenylyl cyclase: a 5-hydroxytryptamine transporter-independent action of this antidepressant compound.

Authors:  Lanqiu Zhang; Mark M Rasenick
Journal:  J Pharmacol Exp Ther       Date:  2009-12-08       Impact factor: 4.030

7.  Disruption of lipid-raft localized Gαs/tubulin complexes by antidepressants: a unique feature of HDAC6 inhibitors, SSRI and tricyclic compounds.

Authors:  Harinder Singh; Nathan Wray; Jeffrey M Schappi; Mark M Rasenick
Journal:  Neuropsychopharmacology       Date:  2018-02-05       Impact factor: 7.853

Review 8.  Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in older patients with depressive illness.

Authors:  M G Harris; P Benfield
Journal:  Drugs Aging       Date:  1995-01       Impact factor: 3.923

Review 9.  Regulation of antidepressant activity by cAMP response element binding proteins.

Authors:  Alana C Conti; Julie A Blendy
Journal:  Mol Neurobiol       Date:  2004-10       Impact factor: 5.590

10.  Chronic antidepressant treatments increase basic fibroblast growth factor and fibroblast growth factor-binding protein in neurons.

Authors:  Alessia Bachis; Alessandra Mallei; Maria Idalia Cruz; Anton Wellstein; Italo Mocchetti
Journal:  Neuropharmacology       Date:  2008-07-18       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.